Alpine Global Management’s Cymabay Therapeutics CBAY Stock Holding History

Alpine Global Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-197,888	Closed	-$584K	–	515
2022 Q2	$584K	Sell	197,888 -52,112	-21%	-$124K	0.15%	73
2022 Q1	$778	Hold	250,000	–	–	0.18%	85
2021 Q4	$845K	Buy	+250,000	New	+$949K	0.12%	168
2021 Q1	–	Sell	-25,339	Closed	-$145K	–	375
2020 Q4	$145K	Buy	+25,339	New	+$192K	0.03%	141
2018 Q2	–	Sell	-14,933	Closed	-$194K	–	125
2018 Q1	$194K	Sell	14,933 -18,864	-56%	-$234K	0.05%	88
2017 Q4	$311K	Buy	+33,797	New	+$289K	0.07%	105

Other funds holding CBAY

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Altium Capital Management New York $42M AUM